273 related articles for article (PubMed ID: 23554887)
21. Discovery of 3-((dimethylamino)methyl)-4-hydroxy-4-(3-methoxyphenyl)-N-phenylpiperidine-1-carboxamide as novel potent analgesic.
Huang H; Wang W; Xu X; Zhu C; Wang Y; Liu J; Li W; Fu W
Eur J Med Chem; 2020 Mar; 189():112070. PubMed ID: 31982651
[TBL] [Abstract][Full Text] [Related]
22. Acute antinociceptive responses in single and combinatorial opioid receptor knockout mice: distinct mu, delta and kappa tones.
Martin M; Matifas A; Maldonado R; Kieffer BL
Eur J Neurosci; 2003 Feb; 17(4):701-8. PubMed ID: 12603260
[TBL] [Abstract][Full Text] [Related]
23. Analysis of [3H]bremazocine binding in single and combinatorial opioid receptor knockout mice.
Simonin F; Slowe S; Becker JA; Matthes HW; Filliol D; Chluba J; Kitchen I; Kieffer BL
Eur J Pharmacol; 2001 Mar; 414(2-3):189-95. PubMed ID: 11239918
[TBL] [Abstract][Full Text] [Related]
24. Further Optimization and Evaluation of Bioavailable, Mixed-Efficacy μ-Opioid Receptor (MOR) Agonists/δ-Opioid Receptor (DOR) Antagonists: Balancing MOR and DOR Affinities.
Harland AA; Yeomans L; Griggs NW; Anand JP; Pogozheva ID; Jutkiewicz EM; Traynor JR; Mosberg HI
J Med Chem; 2015 Nov; 58(22):8952-69. PubMed ID: 26524472
[TBL] [Abstract][Full Text] [Related]
25. HO-CO pathway activation may be associated with hippocampal μ and δ opioid receptors in inhibiting inflammatory pain aversiveness and nociception in WT but not NOS2-KO mice.
Cazuza RA; Arantes ALF; Pol O; Leite-Panissi CRA
Brain Res Bull; 2021 Apr; 169():8-17. PubMed ID: 33422660
[TBL] [Abstract][Full Text] [Related]
26. Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice.
Yang PP; Yeh GC; Yeh TK; Xi J; Loh HH; Law PY; Tao PL
Pharmacol Res; 2016 Sep; 111():867-876. PubMed ID: 27496654
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous targeting of MOR/DOR: A useful strategy for inflammatory pain modulation.
Pasquinucci L; Turnaturi R; Montenegro L; Caraci F; Chiechio S; Parenti C
Eur J Pharmacol; 2019 Mar; 847():97-102. PubMed ID: 30690004
[TBL] [Abstract][Full Text] [Related]
28. The δ opioid receptor agonist SNC80 selectively activates heteromeric μ-δ opioid receptors.
Metcalf MD; Yekkirala AS; Powers MD; Kitto KF; Fairbanks CA; Wilcox GL; Portoghese PS
ACS Chem Neurosci; 2012 Jul; 3(7):505-9. PubMed ID: 22860219
[TBL] [Abstract][Full Text] [Related]
29. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
[TBL] [Abstract][Full Text] [Related]
30. Basal and morphine-evoked dopaminergic neurotransmission in the nucleus accumbens of MOR- and DOR-knockout mice.
Chefer VI; Kieffer BL; Shippenberg TS
Eur J Neurosci; 2003 Oct; 18(7):1915-22. PubMed ID: 14622224
[TBL] [Abstract][Full Text] [Related]
31. Mu and delta opioid receptor immunoreactivity and mu receptor regulation in brainstem cells cultured from late fetal and early postnatal rats.
Kivell BM; Day DJ; McDonald FJ; Miller JH
Brain Res Dev Brain Res; 2004 Mar; 149(1):9-19. PubMed ID: 15013624
[TBL] [Abstract][Full Text] [Related]
32. DPDPE-UK14,304 synergy is retained in mu opioid receptor knockout mice.
Guo XH; Fairbanks CA; Stone LS; Loh HH
Pain; 2003 Jul; 104(1-2):209-17. PubMed ID: 12855331
[TBL] [Abstract][Full Text] [Related]
33. Two delta opioid receptor subtypes are functional in single ventral tegmental area neurons, and can interact with the mu opioid receptor.
Margolis EB; Fujita W; Devi LA; Fields HL
Neuropharmacology; 2017 Sep; 123():420-432. PubMed ID: 28645621
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and Pharmacological Evaluation of Novel C-8 Substituted Tetrahydroquinolines as Balanced-Affinity Mu/Delta Opioid Ligands for the Treatment of Pain.
Nastase AF; Griggs NW; Anand JP; Fernandez TJ; Harland AA; Trask TJ; Jutkiewicz EM; Traynor JR; Mosberg HI
ACS Chem Neurosci; 2018 Jul; 9(7):1840-1848. PubMed ID: 29677442
[TBL] [Abstract][Full Text] [Related]
35. Antinociceptive profile of LP1, a non-peptide multitarget opioid ligand.
Parenti C; Turnaturi R; Aricò G; Marrazzo A; Prezzavento O; Ronsisvalle S; Scoto GM; Ronsisvalle G; Pasquinucci L
Life Sci; 2012 Jun; 90(25-26):957-61. PubMed ID: 22580287
[TBL] [Abstract][Full Text] [Related]
36. Biased Opioid Ligands.
Faouzi A; Varga BR; Majumdar S
Molecules; 2020 Sep; 25(18):. PubMed ID: 32948048
[TBL] [Abstract][Full Text] [Related]
37. Dimerization with cannabinoid receptors allosterically modulates delta opioid receptor activity during neuropathic pain.
Bushlin I; Gupta A; Stockton SD; Miller LK; Devi LA
PLoS One; 2012; 7(12):e49789. PubMed ID: 23272051
[TBL] [Abstract][Full Text] [Related]
38. Opioid-induced down-regulation of RGS4: role of ubiquitination and implications for receptor cross-talk.
Wang Q; Traynor JR
J Biol Chem; 2011 Mar; 286(10):7854-7864. PubMed ID: 21209077
[TBL] [Abstract][Full Text] [Related]
39. Synaptic mechanism for functional synergism between delta- and mu-opioid receptors.
Zhang Z; Pan ZZ
J Neurosci; 2010 Mar; 30(13):4735-45. PubMed ID: 20357124
[TBL] [Abstract][Full Text] [Related]
40. Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice.
Ide S; Minami M; Satoh M; Uhl GR; Sora I; Ikeda K
Neuropsychopharmacology; 2004 Sep; 29(9):1656-63. PubMed ID: 15100703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
